Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes

PURPOSE: To analyse early toxicity of high-dose-rate brachytherapy (HDRB) boost for prostate cancer using 3 fractionation schemes. MATERIAL AND METHODS: From February 2009 to May 2012, after the first course of external beam radiation therapy (EBRT 46 Gy/23 f), 124 patients underwent HDRB boost for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hijazi, Hussam, Chevallier, Daniel, Gal, Jocelyn, Chand, Marie-Eve, Gautier, Mathieu, Hannoun-Levi, Jean-Michel
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2013
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899633/
https://ncbi.nlm.nih.gov/pubmed/24474968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2013.38657
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars